Physician profile
Powell Perng
NPI 1528459815
$5,282.62
in general payments reported to CMS, 2019-2025
21 companies · $1,315 in 2025
The $1,315 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $416 · 2023: $1,194 · 2024: $2,357 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,766 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,766.30 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,186.84 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $752.22 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $597.95 | 2024-2025 | |
| Genzyme Corporation | $487.91 | 2022-2025 | |
| Pfizer INC. | $294.80 | 2023-2025 | |
| Lilly USA, LLC | $240.06 | 2022-2025 | Olumiant, Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $233.89 | 2022-2023 | Levulan Kerastick, Winlevi, Odomzo |
| Janssen Biotech, INC. | $218.17 | 2022-2025 | Tremfya, Simponi, Simponi Aria |
| Incyte Corporation | $215.66 | 2022-2025 | Opzelura |
| Dermavant Sciences, INC. | $201.31 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $185.94 | 2023-2025 | Dupixent, Libtayo |
| Ucb, INC. | $129.70 | 2024-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $108.79 | 2023-2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $99.99 | 2024 | |
| Leo Pharma INC. | $99.34 | 2022-2025 | Adbry |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $70.80 | 2023-2024 | Zoryve |
| Almirall LLC | $50.26 | 2022-2025 | Klisyri |
| Mallinckrodt Hospital Products INC. | $44.29 | 2024-2025 | Acthar |
| Organon LLC | $29.05 | 2025 | Vtama |
| Amgen INC. | $21.09 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.56 | 2023 | Duobrii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Powell Perng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.